This video demonstrates a protocol for assessing the activation of dendritic cells using immunoglobulin G (IgG)-coated tumor cells. Dendritic cells internalize the IgG-coated tumor cells, process the tumor antigens, and present them on the surface through MHC-II molecules, along with the co-expression of the costimulatory molecule CD86. These dendritic cells then undergo MHC-II and CD86-targeted immunostaining and flow cytometry analysis to identify their activation state.
Protocol
All procedures involving sample collection have been performed in accordance with the institute's IRB guidelines. 1. Isolation of Tumor-Associated Monocyte-Derived Dendritic Cells In a laminar flow hood, remove tumors from CO2 euthanized mice and place tumors in RPMI medium without fetal bovine serum (FBS). NOTE: Shaving the mice and spraying them with 70% ethanol before removing the tumors is highly recommend…